Infertility |
|
|
Clinical Trial: Assessing Women's Attitudes About the Risk of Infertility Related to Adjuvant Therapy for Early Breast Cancer
This study is currently recruiting patients.
|
Purpose
RATIONALE: Adjuvant therapy given after surgery for early breast cancer may cause infertility. Assessing young women's attitudes and feelings about the risk of infertility may help improve the ability to plan effective treatment.
PURPOSE: Clinical trial to study young women's attitudes and feelings about the risk of infertility related to adjuvant therapy for stage I or stage II breast cancer.
| Condition | Treatment or Intervention |
|---|---|
| sexual dysfunction and infertility sexuality and reproductive issues psychosocial effects/treatment stage I breast cancer stage II breast cancer | Procedure: psychosocial assessment/care Procedure: supportive care/therapy |
MedlinePlus related topics: Breast Cancer
Genetics Home Reference related topics: breast cancer
Study Type: Interventional
Study Design: Treatment
Official Title: Study of Attitudes Toward the Risk of Infertility Related to Adjuvant Therapy in Women With Early Breast Cancer
OBJECTIVES:
- Determine the attitude toward the risk of infertility related to adjuvant therapy in women with early breast cancer.
- Correlate, if possible, the patient's attitude with the fact that the patient already has children or the time interval between the date of breast cancer diagnosis and the date of study participation.
OUTLINE: This is a multicenter study.
Patients complete a questionnaire administered by a nontreating physician.
PROJECTED ACCRUAL: A total of 385 patients will be accrued for this study.
Eligibility
Ages Eligible for Study: up to 35 Years, Genders Eligible for Study: Both
Criteria
DISEASE CHARACTERISTICS:
- Histologically or cytologically confirmed prior or current diagnosis of breast cancer
- Stage I or II
- No relapsed disease
- No evidence of infertility
- Regular menses or regular hormonal contraception use for the past 3 months
- Hormonal status:
- Not specified
PATIENT CHARACTERISTICS: Age
- 35 and under at diagnosis
Sex
- Female
Menopausal status
- Premenopausal
Performance status
- Not specified
Life expectancy
- Not specified
Hematopoietic
- Not specified
Hepatic
- Not specified
Renal
- Not specified
Other
- No psychological, familial, sociological, or geographical condition that would preclude study compliance
PRIOR CONCURRENT THERAPY: Biologic therapy
- Not specified
Chemotherapy
- Not specified
Endocrine therapy
- See Disease Characteristics
Radiotherapy
- Not specified
Surgery
- Not specified
Location and Contact Information
Belgium
Algemeen Ziekenhuis Sint-Augustinus, Wilrijk, 2610, Belgium; Recruiting
Centre Hospitalier Etterbeek Ixelles, Brussels, B-1050, Belgium; Recruiting
CHU Liege - Domaine Universitaire du Sart Tilman, LIEGE, B-4000, Belgium; Recruiting
Institut Jules Bordet, Brussels, 1000, Belgium; Recruiting
Croatia
University Hospital Rebro, Zagreb, 41000, Croatia; Recruiting
Germany
Klinikum der J.W. Goethe Universitaet, Frankfurt, D-60590, Germany; Recruiting
Italy
Ospedale Alessandro Manzoni, Lecco, 23900, Italy; Recruiting
Lebanon
American University of Beirut Medical Center, Beirut, 113-6044, Lebanon; Recruiting
Netherlands
Academisch Medisch Centrum, Amsterdam, 1105 AZ, Netherlands; Recruiting
Arnhems Radiotherapeutisch Instituut, ARNHEM, 6815 AD, Netherlands; Recruiting
Peru
Instituto de Enfermedades Neoplasicas, Lima, 34, Peru; Recruiting
Portugal
Instituto Portugues de Oncologia de Francisco Gentil - Centro Regional de Oncologia de Lisboa, S.A., Lisboa, 1099-023 Codex, Portugal; Recruiting
South Africa
Groote Schuur Hospital, Cape Town, 7925, South Africa; Recruiting
Switzerland
Inselspital, Bern, Bern, CH-3010, Switzerland; Recruiting
Kantonsspital - St. Gallen, St. Gallen, CH-9007, Switzerland; Recruiting
Turkey
Marmara University Hospital, Istanbul, 81190, Turkey; Recruiting
Yugoslavia
Institute of Oncology and Radiology of Serbia, BELGRADE, 11000, Yugoslavia; Recruiting
Angelo Di Leo, MD, Misericordia e Dolce Hospital
More Information
Clinical trial summary from the National Cancer Institute's PDQ® database
Record last reviewed: March 2005
Last Updated: March 15, 2005
Record first received: June 5, 2003
ClinicalTrials.gov Identifier: NCT00062400
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 8, 2005

Not Signed In -


